Galaxy Surfactants (GALAXYSURF) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
8 Sep, 2026Executive summary
Q3 FY26 saw resilient performance with consolidated volumes stable year-on-year, as high single-digit growth in Specialty Care offset softness in Performance Surfactants.
EBITDA rose 13% year-on-year to ₹124 crore, driven by Specialty segment strength in India and ROW, with EBITDA per metric ton improving to ₹20,156.
Domestic volumes grew mid-single digits, led by Non-Tier-1 and D2C customers, while AMET region volumes declined in the high teens due to competition.
The company launched five new Sun Care products under the GALSORB SunBliss range, with commercialization set for Q4 FY26, and initiated a rebranding to expand into beauty, derma, and wellness.
Unaudited consolidated and standalone financial results for the quarter and nine months ended 31st December 2025 were approved by the Board on 13th February 2026.
Financial highlights
Q3FY26 consolidated revenue from operations was ₹1,329.49 crore, up from ₹1,041.69 crore in Q3 FY25; nine-month revenue was ₹3,933.58 crore, up from ₹3,078.74 crore year-over-year.
Q3FY26 EBITDA grew 13% year-on-year to ₹124 crore; 9MFY26 EBITDA flat at ₹376 crore.
Q3FY26 PAT declined 8.8% year-on-year to ₹58.97 crore; nine-month PAT was ₹204.95 crore, down from ₹229.04 crore year-over-year.
Q3FY26 EBITDA margin at 9.3% vs 10.5% YoY; PAT margin at 4.4% vs 6.2% YoY.
Exceptional item of ₹11.9 crore recognized in Q3FY26 due to new Labour Codes, affecting both consolidated and standalone results.
Outlook and guidance
Management expects growth momentum to regain in coming quarters, supported by GST reforms, U.S.-India tariff revisions, and continued premiumization of the Specialty portfolio.
India volumes expected to increase incrementally in both tier one and non-tier one accounts; double-digit Specialty segment growth anticipated.
AMET region expected to recover volumes from Q4 onwards, though not to previous peak levels due to structural market changes.
Rest of the world to maintain growth momentum, with North America benefiting from tariff reduction starting late Q4 and Q1 next year.
Management continues to monitor regulatory developments regarding Labour Codes and will assess further accounting implications as guidance emerges.
Latest events from Galaxy Surfactants
- 8% volume growth and ₹79.72 Cr net profit, with new EU subsidiary and supply chain challenges.GALAXYSURF
Q1 24/25 - ROW and Specialty Care drove growth as margins held firm amid supply chain and price volatility.GALAXYSURF
Q2 24/25 - Q3 volumes fell 1% YoY, margins declined, but international growth and recovery outlook remain.GALAXYSURF
Q3 24/25 - FY25 revenue up 11% with strong ROW growth, margin pressure from input costs, and cautious FY26 outlook.GALAXYSURF
Q4 24/25 - Volumes and revenue rose, but margins narrowed amid input cost and legal risks.GALAXYSURF
Q1 25/26 - Revenue up 24.8% YoY, but margins declined amid higher feedstock costs and tariff headwinds.GALAXYSURF
Q2 25/26 - Revenue rose but margins and profit declined amid global disruptions; ₹22/share dividend proposed.GALAXYSURF
Q4 25/26 - Quarterly EBITDA hit INR 252.5 crores, with strong revenue, profit growth, and upgraded guidance.GALAXYSURF
Q1 26/27